Dexamethasone Kalceks

1. Systemic use
Dexamethasone Kalceks solution for injection/infusion is often used following emergency treatment initiated at high dose:

• Treatment and prophylaxis of cerebral oedema in brain tumours (postoperatively and after X-ray radiation) and after spinal cord trauma.
• State of anaphylactic shock (e.g. contrast medium reaction) in combination with adrenaline, antihistamines and appropriate volume replacement (caution: mixed syringes).
• Polytraumatic shock / prophylaxis of post-traumatic shock lung.
• Severe exacerbations of asthma (only with concomitant sympathomimetics).
• Acute severe dermatosis (e.g. pemphigus vulgaris, erythroderma).
• Severe blood diseases (e.g. acute thrombocytopenic purpura, haemolytic anaemia, as concomitant medication as part of leukaemia treatments).
• As second-line treatment for acute adrenocortical insufficiency (Addisonian crisis).

Dexamethasone Kalceks is indicated in the treatment of coronavirus disease 2019 (COVID-19) in adult and adolescent patients (aged 12 years and older with body weight at least 40 kg) who require supplemental oxygen therapy.

2. Local use

• Periarticular and infiltrative therapy, e.g. in periarthritis scapulohumeralis, epicondylitis, bursitis, tendovaginitis, styloiditis.
• Intraarticular injection, e.g. in rheumatoid arthritis, if individual joints are affected or respond inadequately to systemic treatment, accompanying inflammatory reactions in rheumatoid arthritis.

Prescription-only medicine. Information for healthcare professionals only.
For full information about this medicine, refer to the Summary of Product Characteristics.
Advertisement developed or revised 05/2026. Advertiser: AS Kalceks.